115 related articles for article (PubMed ID: 35953408)
1. HLA homozygosity is associated with Non-Hodgkin lymphoma.
Roark CL; Ho BE; Aubrey MT; Anobile C; Israeli S; Phang TL; Braxton D; Ho AP; Freed BM
Hum Immunol; 2022 Oct; 83(10):730-735. PubMed ID: 35953408
[TBL] [Abstract][Full Text] [Related]
2. HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes.
Wang SS; Carrington M; Berndt SI; Slager SL; Bracci PM; Voutsinas J; Cerhan JR; Smedby KE; Hjalgrim H; Vijai J; Morton LM; Vermeulen R; Paltiel O; Vajdic CM; Linet MS; Nieters A; de Sanjose S; Cozen W; Brown EE; Turner J; Spinelli JJ; Zheng T; Birmann BM; Flowers CR; Becker N; Holly EA; Kane E; Weisenburger D; Maynadie M; Cocco P; Albanes D; Weinstein SJ; Teras LR; Diver WR; Lax SJ; Travis RC; Kaaks R; Riboli E; Benavente Y; Brennan P; McKay J; Delfau-Larue MH; Link BK; Magnani C; Ennas MG; Latte G; Feldman AL; Doo NW; Giles GG; Southey MC; Milne RL; Offit K; Musinsky J; Arslan AA; Purdue MP; Adami HO; Melbye M; Glimelius B; Conde L; Camp NJ; Glenn M; Curtin K; Clavel J; Monnereau A; Cox DG; Ghesquières H; Salles G; Bofetta P; Foretova L; Staines A; Davis S; Severson RK; Lan Q; Brooks-Wilson A; Smith MT; Roman E; Kricker A; Zhang Y; Kraft P; Chanock SJ; Rothman N; Hartge P; Skibola CF
Cancer Res; 2018 Jul; 78(14):4086-4096. PubMed ID: 29735552
[TBL] [Abstract][Full Text] [Related]
3. [The impact of HLA high resolution typing mismatching of donor-recipient pairs on outcome of unrelated donor hematopoietic stem cell transplantation].
He J; Xu C; Wu XJ; Bao XJ; Qiu QC; Yuan XN; Li Y; Shen HJ; Wu DP; Hong JL; Liu JH; DU HY; Zhang L; DU D; Lu J; Liu J
Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):353-7. PubMed ID: 22781790
[TBL] [Abstract][Full Text] [Related]
4. Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology.
Wang SS; Abdou AM; Morton LM; Thomas R; Cerhan JR; Gao X; Cozen W; Rothman N; Davis S; Severson RK; Bernstein L; Hartge P; Carrington M
Blood; 2010 Jun; 115(23):4820-3. PubMed ID: 20385791
[TBL] [Abstract][Full Text] [Related]
5. Haplotype-specific pattern of association of human major histocompatibility complex with non-Hodgkin's lymphoma outcome.
Nowak J; Kalinka-Warzocha E; Juszczyński P; Mika-Witkowska R; Zajko M; Graczyk-Pol E; Coiffier B; Salles G; Warzocha K
Tissue Antigens; 2008 Jan; 71(1):16-26. PubMed ID: 17971052
[TBL] [Abstract][Full Text] [Related]
6. HLA class II polymorphism in Egyptian children with lymphomas.
Al-Tonbary Y; Abdel-Razek N; Zaghloul H; Metwaly S; El-Deek B; El-Shawaf R
Hematology; 2004 Apr; 9(2):139-45. PubMed ID: 15203870
[TBL] [Abstract][Full Text] [Related]
7. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
[TBL] [Abstract][Full Text] [Related]
8. Association of HLA alleles with non-Hodgkin's lymphoma in Korean population.
Choi HB; Roh SY; Choi EJ; Yoon HY; Kim SY; Hong YS; Kim DW; Kim TG
Int J Hematol; 2008 Mar; 87(2):203-209. PubMed ID: 18301962
[TBL] [Abstract][Full Text] [Related]
9. Human leukocyte antigens and genetic susceptibility to lymphoma.
McAulay KA; Jarrett RF
Tissue Antigens; 2015 Aug; 86(2):98-113. PubMed ID: 26189878
[TBL] [Abstract][Full Text] [Related]
10. SNP variants associated with non-Hodgkin lymphoma (NHL) correlate with human leukocyte antigen (HLA) class II expression.
Ten LC; Chin YM; Tai MC; Chin EF; Lim YY; Suthandiram S; Chang KM; Ong TC; Bee PC; Mohamed Z; Gan GG; Ng CC
Sci Rep; 2017 Jan; 7():41400. PubMed ID: 28139690
[TBL] [Abstract][Full Text] [Related]
11. Variation in effects of non-Hodgkin lymphoma risk factors according to the human leukocyte antigen (HLA)-DRB1*01:01 allele and ancestral haplotype 8.1.
Wang SS; Lu Y; Rothman N; Abdou AM; Cerhan JR; De Roos A; Davis S; Severson RK; Cozen W; Chanock SJ; Bernstein L; Morton LM; Hartge P
PLoS One; 2011; 6(11):e26949. PubMed ID: 22096508
[TBL] [Abstract][Full Text] [Related]
12. HLA DR-DQ combination associated with the increased risk of developing human HCV positive non-Hodgkin's lymphoma is related to the type II mixed cryoglobulinemia.
De Re V; Caggiari L; Monti G; Libra M; Spina M; Dolcetti R; De Zorzi M; Racanelli V; Crovatto M; Toffoli G
Tissue Antigens; 2010 Feb; 75(2):127-35. PubMed ID: 20002609
[TBL] [Abstract][Full Text] [Related]
13. The associations of HLA-A, -B, DRB1 alleles and haplotypes in Turkish lymphoma patients.
Uçar F; Sönmez M; Ermantaş N; Özbaş HM; Cansız A; Balcı M; Yılmazz M
Gene; 2016 Jul; 586(2):263-7. PubMed ID: 27063556
[TBL] [Abstract][Full Text] [Related]
14. HLA-A*02:06 allele may be susceptible to myelodysplastic syndrome in Zhejiang Han population, China.
Chen N; Wang F; Zhao Y; Dong L; Wang W; Zhang W; He J; Zhu F
Int J Immunogenet; 2023 Oct; 50(5):233-242. PubMed ID: 37485595
[TBL] [Abstract][Full Text] [Related]
15. Heterozygote advantage at HLA class I and II loci and reduced risk of colorectal cancer.
Tsai YY; Qu C; Bonner JD; Sanz-Pamplona R; Lindsey SS; Melas M; McDonnell KJ; Idos GE; Walker CP; Tsang KK; Da Silva DM; Moratalla-Navarro F; Maoz A; Rennert HS; Kast WM; Greenson JK; Moreno V; Rennert G; Gruber SB; Schmit SL
Front Immunol; 2023; 14():1268117. PubMed ID: 37942321
[TBL] [Abstract][Full Text] [Related]
16. HLA-A*26 and susceptility of iranian patients with non-Hodgkin lymphoma.
Sayad A; Akbari MT; Mehdizadeh M; Taheri M; Hajifathali A
Iran J Immunol; 2014 Dec; 11(4):269-74. PubMed ID: 25549594
[TBL] [Abstract][Full Text] [Related]
17. A preliminary study of HLA class II alleles in Thai patients with non Hodgkin's lymphoma.
Nathalang O; Tatsumi N; Hino M; Yamane T; Prayoonwiwat W; Suwanasophon C; Sriphaisal T
Osaka City Med J; 1997 Dec; 43(2):253-8. PubMed ID: 9540346
[TBL] [Abstract][Full Text] [Related]
18. Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci.
Wang SS; Vajdic CM; Linet MS; Slager SL; Voutsinas J; Nieters A; de Sanjose S; Cozen W; Alarcón GS; Martinez-Maza O; Brown EE; Bracci PM; Lightfoot T; Turner J; Hjalgrim H; Spinelli JJ; Zheng T; Morton LM; Birmann BM; Flowers CR; Paltiel O; Becker N; Holly EA; Kane E; Weisenburger D; Maynadie M; Cocco P; Foretova L; Staines A; Davis S; Severson R; Cerhan JR; Breen EC; Lan Q; Brooks-Wilson A; De Roos AJ; Smith MT; Roman E; Boffetta P; Kricker A; Zhang Y; Skibola C; Chanock SJ; Rothman N; Benavente Y; Hartge P; Smedby KE
Am J Epidemiol; 2015 Mar; 181(6):406-21. PubMed ID: 25713336
[TBL] [Abstract][Full Text] [Related]
19. Cost of Disease Progression in Patients with Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Non-Hodgkin's Lymphoma.
Reyes C; Engel-Nitz NM; DaCosta Byfield S; Ravelo A; Ogale S; Bancroft T; Anderson A; Chen M; Matasar M
Oncologist; 2019 Sep; 24(9):1219-1228. PubMed ID: 30808814
[TBL] [Abstract][Full Text] [Related]
20. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
